Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type
- 31 December 1998
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 59 (12) , 837-845
- https://doi.org/10.1016/s0011-393x(98)85048-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer's diseaseClinical Therapeutics, 1998
- Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseLife Sciences, 1996
- THE CHOLINERGIC HYPOTHESIS—TEN YEARS ONBritish Medical Bulletin, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- “Mini-mental state”Journal of Psychiatric Research, 1975
- Validity of the Trail Making Test as an Indicator of Organic Brain DamagePerceptual and Motor Skills, 1958